compound semaglutide or tirzepatide So, here's a quick breakdown: (Wegovy/Ozempic) is a GLP-1 receptor agonist — it mimics a gut hormone that regulates appetite and blood sugar. (Zepbound/Mounjaro) is a dual GIP/GLP-1 agonist — Understanding Compounded Tirzepatide and Semaglutide

Retatrutide raises heart rate ~57 bpm, more than Ozempic or Mounjaro

Learn about Semaglutide at Nowak Aesthetics, please contact us online if you would like to schedule an appointment or have questions.

Here's what you need to know:

The demand for GLP-1 medications is rapidly increasing, with the market expected to reach $13.6 billion globally by 2028 (source: Research and Markets)

Merck had other China deals in the last few months (LaNova Medicines and Curon Biopharmaceutical), but all deals are either early-stage (ongoing Phase 1) or pre-clinical (Hansoh)

GLP-1 medications begin reducing appetite within days, but meaningful weight loss typically emerges over weeks and months